The ClearWave is a lightweight, easy-to-use solution that employs blue light technology to target acne-causing bacteria without the side effects that can accompany many oral or topical treatments. Blue light is ideal for sensitive skin; it does not cause the itching, burning, drying, flaking or sun sensitivity associated with some acne medications.
FTC Chairman Jon Leibowitz said in a statement that while smartphones make our lives easier in countless ways, but “unfortunately when it comes to curing acne, there’s no app for that”.
Founded in 1956, Verilux, Inc., the “Healthy Lighting Company,” is a pioneer in the design and manufacture of lifestyle products utilizing Natural Spectrum® lighting technology. The company offers a wide range of high quality home, office, and travel products engineered to improve vision, help alleviate the symptoms of seasonal light changes and the Winter Blues, aid in sleeping, sanitize surfaces without the use of chemicals, and clear and rejuvenate the skin. Verilux, which is Latin for “true light,” is committed to supporting balanced and healthy lifestyles that benefit everyone and the world around us. Verilux calls this “life in a better light.” Visit Verilux online at Verilux.com, Facebook.com/Verilux and @Verilux on Twitter.
In a watershed moment, the FTC this week fined two app developers who falsely advertised that their smartphone apps could treat acne. The apps, AcneApp and Acne Pwner, were sold in the iTunes App Store and Android Marketplace, respectively. The settlements ban the developers from stating certain health-related claims without scientific evidence. AcneApp’s developer has to pay the FTC $14,294 and the developer of Acne Pwnder must pay $1,700.
The Commission vote to approve the administrative complaints and proposed consent agreements was 5-0. The FTC will publish a description of the consent agreement package in the Federal Register shortly. The agreement will be subject to public comment for 30 days, beginning today and continuing through October 10, 2011, after which the Commission will decide whether to make the proposed consent order final.
The ClearWave Phototherapy System for Acne has been through the 510K process and is FDA cleared for over-the-counter treatment of mild to moderate inflammatory acne. Additional product information is available in the FDA medical devices database.
